Alcon, Inc.:市場シェア分析...市場調査レポートについてご紹介

【英文タイトル】Alcon, Inc. Market Share Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 12
2 Introduction 14
2.1 What Is This Report About? 14
3 Definitions of Markets/Categories Covered 15
3.1 Ophthalmic Devices 15
3.1.1 Cataract Surgery Devices 15
3.1.2 Glaucoma Surgery Devices 15
3.1.3 Intraocular Lens (IOL) 15
3.1.4 Refractive Surgery Devices 15
3.1.5 Vision Care 15
3.1.6 Vitreo Retinal Surgery Devices 15
4 Company Snapshot 16
4.1 Key Information 16
4.2 Company Overview 16
4.3 SWOT Snapshot 16
4.4 Business Overview 17
4.5 Major Products and Services 18
4.5.1 Overview 18
5 History 19
6 SWOT Analysis 23
6.1 Overview 23
6.2 Alcon, Inc. Strengths 23
6.2.1 Strong Financial Capabilities 23
6.2.2 Market Leadership 24
6.2.3 Diversified Geographical Presence 24
6.3 Alcon, Inc. Weaknesses 24
6.3.1 Decrease in Cash Reserves 24
6.3.2 Patent Infringement Lawsuits 24
6.4 Alcon, Inc. Opportunities 25
6.4.1 Emerging Markets 25
6.4.2 Growing Aged Population 25
6.4.3 Global Ophthalmic Devices Market 25
6.4.4 Inorganic Growth Drivers 26
6.4.5 New Product Launches and Strong Pipeline 26
6.5 Alcon, Inc. Threats 26
6.5.1 Uncertain R&D Outcomes 26
6.5.2 Regulatory Requirements 26
6.5.3 Cost Containment Pressures 26
6.5.4 Industry Consolidation 27
6.5.5 Intense Competition 27
7 Competitors 28
8 Competitive Landscape 29
8.1 Ophthalmic Devices (Cataract Surgery Devices), Global, Market Share (%), 2011 29
8.2 Alcon, Inc., Ophthalmic Devices (Cataract Surgery Devices), by Region, Market Share (2011) 30
8.3 Alcon, Inc., Ophthalmic Devices (Cataract Surgery Devices), by Country, Market Share (2011) 31
8.4 Ophthalmic Devices (Glaucoma Surgery Devices), Global, Market Share (%), 2011 33
8.5 Alcon, Inc., Ophthalmic Devices (Glaucoma Surgery Devices), by Region, Market Share (2011) 34
8.6 Alcon, Inc., Ophthalmic Devices (Glaucoma Surgery Devices), by Country, Market Share (2011) 35
8.7 Ophthalmic Devices (Intraocular Lens (IOL)), Global, Market Share (%), 2011 37
8.8 Alcon, Inc., Ophthalmic Devices (Intraocular Lens (IOL)), by Region, Market Share (2011) 38
8.9 Alcon, Inc., Ophthalmic Devices (Intraocular Lens (IOL)), by Country, Market Share (2011) 39
8.10 Ophthalmic Devices (Refractive Surgery Devices), Global, Market Share (%), 2011 41
8.11 Alcon, Inc., Ophthalmic Devices (Refractive Surgery Devices), by Region, Market Share (2011) 43
8.12 Alcon, Inc., Ophthalmic Devices (Refractive Surgery Devices), by Country, Market Share (2011) 44
8.13 Ophthalmic Devices (Vision Care), Global, Market Share (%), 2011 46
8.14 Alcon, Inc., Ophthalmic Devices (Vision Care), by Region, Market Share (2011) 47
8.15 Alcon, Inc., Ophthalmic Devices (Vision Care), by Country, Market Share (2011) 48
8.16 Ophthalmic Devices (Vitreo Retinal Surgery Devices), Global, Market Share (%), 2011 50
8.17 Alcon, Inc., Ophthalmic Devices (Vitreo Retinal Surgery Devices), by Region, Market Share (2011) 51
8.18 Alcon, Inc., Ophthalmic Devices (Vitreo Retinal Surgery Devices), by Country, Market Share (2011) 52
9 Alcon, Inc. Medical Equipment Market Share Analysis 54
9.1 Alcon, Inc., Ophthalmic Devices, Global, Category Revenue Share (2011) 54
9.2 Alcon, Inc., Asia-Pacific, Category Revenue Share (2011) 56
9.2.1 Alcon, Inc., Australia, Category Revenue Share (2011) 58
9.2.2 Alcon, Inc., China, Category Revenue Share (2011) 60
9.2.3 Alcon, Inc., India, Category Revenue Share (2011) 62
9.2.4 Alcon, Inc., Japan, Category Revenue Share (2011) 64
9.2.5 Alcon, Inc., Other Asia-Pacific, Category Revenue Share (2011) 66
9.3 Alcon, Inc., Europe, Category Revenue Share (2011) 68
9.3.1 Alcon, Inc., France, Category Revenue Share (2011) 70
9.3.2 Alcon, Inc., Germany, Category Revenue Share (2011) 72
9.3.3 Alcon, Inc., Italy, Category Revenue Share (2011) 74
9.3.4 Alcon, Inc., Spain, Category Revenue Share (2011) 76
9.3.5 Alcon, Inc., United Kingdom, Category Revenue Share (2011) 78
9.3.6 Alcon, Inc., Other Europe, Category Revenue Share (2011) 80
9.4 Alcon, Inc., Middle East and Africa, Category Revenue Share (2011) 82
9.5 Alcon, Inc., North America, Category Revenue Share (2011) 84
9.5.1 Alcon, Inc., Canada, Category Revenue Share (2011) 86
9.5.2 Alcon, Inc., United States, Category Revenue Share (2011) 88
9.6 Alcon, Inc., South and Central America, Category Revenue Share (2011) 90
9.6.1 Alcon, Inc., Brazil, Category Revenue Share (2011) 92
9.6.2 Alcon, Inc., Other South and Central America, Category Revenue Share (2011) 94
10 Key Employees 96
11 Key Employee Biographies 97
12 Locations And Subsidiaries 98
12.1 Head Office 98
12.2 Other Locations & Subsidiaries 98
13 Financial Deals Landscape 103
13.1 Alcon, Inc., Deals Volume Summary, 2007 to 2012 103
14 Alcon, Inc., Deals Summary By Region, 2007 to 2012 104
15 Alcon, Inc. Detailed Deal Summary 106
15.1 Partnerships 106
15.1.1 IRIDEX Enters Into Licensing Agreement With Alcon 106
15.1.2 Alcon Enters Into Licensing Agreement With Advanced Medical Optics 107
15.1.3 Advanced Medical Optics Enters Into Licensing Agreement With Alcon 108
15.2 Acquisition 109
15.2.1 Novartis Completes Acquisition Of Remaining 23% Stake In Alcon 109
15.2.2 Novartis Completes Acquisition Of Additional 52% Stake In Alcon From Nestle 111
15.2.3 Alcon Completes Acquisition Of Optonol 114
15.2.4 Alcon Acquires Additional 17.6% Stake In WaveLight 116
15.2.5 Novartis Acquires 25% Stake In Alcon From Nestle 117
16 Recent Developments 119
16.1 Strategy And Business Planning 119
16.1.1 Dec 14, 2009: Alcon To Enter Surgical Glaucoma Market By Acquiring Optonol 119
16.1.2 Oct 23, 2009: Potentia Seals Licensing, Purchase Option Agreements With Alcon 119
16.1.3 Jul 22, 2009: Alcon Signs Agreement With AstraZeneca On Eye Drug Development 120
16.1.4 May 25, 2009: Alcon Begins Construction Of Manufacturing Plant In Singapore 120
16.1.5 Feb 11, 2009: Alcon To Cut 260 Work Force 121
16.1.6 Sep 19, 2008: Alcon Announces Expansion Plan In West Virginia 121
16.1.7 Sep 10, 2007: Alcon To Expand Swiss Operations 122
16.2 Financial Announcements 122
16.2.1 Jan 27, 2011: Alcon Reports Sales Of $7.17 Billion In 2010 122
16.2.2 Oct 20, 2010: Alcon Reports Net Income Of $446 Million For Q3 2010 123
16.2.3 Jul 26, 2010: Alcon Reports Net Earnings Of $670 Million In Q2 2010 124
16.2.4 Apr 26, 2010: Alcon Reports Net Earnings Of $573 Million In Q1 2010 125
16.2.5 Feb 11, 2010: Alcon Reports Net Earnings Of $2 Billion In 2009 126
16.2.6 Oct 27, 2009: Alcon Reports Net Earnings Of $515 Million In Q3 2009 128
16.2.7 Jul 22, 2009: Alcon Posts Net Earnings Of $582 Million For Q2 2009 130
16.2.8 Jul 22, 2009: Alcon Reports Strong Financial Results For Second Quarter 131
16.2.9 Apr 22, 2009: Alcon Posts Net Earnings Of $452 Million For Q1 2009 131
16.2.10 Feb 11, 2009: Alcon Reports 2008 Results 133
16.2.11 Jan 08, 2009: Alcon To Declare 2008 Results 134
16.2.12 Oct 22, 2008: Alcon Reports 3Q 2008 Results 135
16.2.13 Oct 22, 2008: Alcons Third Quarter Sales Rise 14.1 Percent 137
16.2.14 Oct 01, 2008: Alcon To Declare 3Q 2008 Results 138
16.2.15 Jul 23, 2008: Alcon Reports 2Q 2008 Results 139
16.2.16 Jul 23, 2008: Alcons Second Quarter Sales Rise 17.9 Percent; Net Earnings Increase 26.3 Percent 141
16.2.17 Jun 17, 2008: Alcon To Declare Q2 2008 Results 143
16.2.18 May 06, 2008: Alcon Approves Dividend 143
16.2.19 Apr 23, 2008: Alcon Declares Q1 2008 Results 143
16.2.20 Apr 23, 2008: Alcons First Quarter Sales Rise 16.2 Percent; Net Income Increases 24.0 Percent 145
16.2.21 Mar 28, 2008: Alcon To Declare Q1 2008 Results 145
16.2.22 Feb 06, 2008: Alcon Declares Q4 2007 Results 146
16.2.23 Feb 06, 2008: Alcons Fourth Quarter Sales Rise 20.0 Percent 147
16.2.24 Oct 24, 2007: Alcons Third Quarter Sales Rise 11.0 Percent 149
16.2.25 Oct 24, 2007: Alcon Declares Q3 2007 Results 151
16.2.26 Jul 25, 2007: Alcon Declares Q2 2007 Results 152
16.2.27 Jul 25, 2007: Alcons Second Quarter Sales Rise 12.3 Percent 154
16.2.28 May 09, 2007: Alcon Approves Dividend 155
16.2.29 Apr 25, 2007: Alcon’s Q1 Global Sales Up By 14.3% 155
16.2.30 Apr 25, 2007: Alcons First Quarter Sales Rise 14.3 Percent 157
16.2.31 Mar 26, 2007: Alcon Announces Q1 2007 Financial Release Date 159
16.2.32 Feb 07, 2007: Alcon Declares Q4 2006 Results 159
16.2.33 Feb 07, 2007: Alcons Fourth Quarter Sales Rise 16.1 Percent 161
16.2.34 Oct 23, 2006: Alcons Third Quarter Sales Rise 12.4 Percent 163
16.2.35 Oct 23, 2006: Alcon’s Q3 Global Sales Up By 12.4% 165
16.2.36 Sep 18, 2006: Alcon Announces Q3 2006 Financial Release Date 166
16.2.37 Sep 08, 2006: Alcon Approves Repurchase Of 5 Million Additional Shares 167
16.2.38 Jul 24, 2006: Alcon’s Q2 Global Sales Up 11.8% To $1,310.8 Million 167
16.2.39 Jul 24, 2006: Alcons Second Quarter Sales Rise 11.8 Percent 169
16.2.40 Jun 19, 2006: Alcon Announces Q2 2006 Financial Release Date 169
16.2.41 May 02, 2006: Alcon Approves Dividend 170
16.2.42 Apr 24, 2006: Alcons First Quarter Sales Rise 8.1 Percent, Net Earnings Increase 18.5 Percent 170
16.2.43 Feb 08, 2006: Alcons Fourth Quarter Sales Rise 10.7 Percent 172
16.2.44 Oct 19, 2005: Alcon’s Third Quarter Earnings Rise 52.2 Percent On 11.8 Percent Sales Growth 174
16.2.45 Jul 27, 2005: Alcons Second Quarter Sales Increase 12.8 Percent 175
16.2.46 Apr 21, 2005: Alcon’s First Quarter Earnings Rise 30.6 Percent On 11.1 Percent Sales Growth 176
16.2.47 Feb 09, 2005: Alcons Fourth Quarter Earnings Rise 39.9 Percent On 11.9 Percent Sales Growth 177
16.2.48 Oct 20, 2004: Alcons Third Quarter Earnings Rise 26.9 Percent On 16.5 Percent Sales Growth 180
16.2.49 Jul 28, 2004: Alcons Second Quarter Earnings Rise 67.9 Percent On 12.3 Percent Sales Growth 180
16.2.50 Jul 13, 2004: Alcon Provides Estimate Of Second Quarter Earnings 180
16.2.51 Apr 20, 2004: Alcons First Quarter Earnings Rise 46.7 Percent On 19.4 Percent Sales Growth 181
16.2.52 Feb 11, 2004: Alcons Fourth Quarter Sales Grow 13.7 Percent 182
16.2.53 Oct 22, 2003: Alcons Third-Quarter Earnings Rise 22.4 Percent As Sales Increase 10.6 Percent 184
16.2.54 Jul 30, 2003: Alcon Reports Strong Second Quarter And Six Month 2003 Results 186
16.2.55 Apr 22, 2003: Alcons First Quarter Net Earnings Rose 38.5% On 14.2% Sales Increase 188
16.2.56 Feb 19, 2003: Alcon Reports Strong Fourth Quarter And Full Year 2002 Results 190
16.2.57 Oct 24, 2002: Alcon Reports Third Quarter Operating Results 192
16.2.58 Jul 31, 2002: Alcon Reports Second Quarter Operating Results 194
16.2.59 May 02, 2002: Alcon Reports 17.9 Percent Increase in First Quarter Earnings Per Share 196
16.2.60 Apr 10, 2002: Alcon Posts First Quarter Sales Of $706.5 Million 197
16.3 Research And Development 198
16.3.1 Oct 26, 2009: Potentia Pharmaceuticals Enters Into Licensing, Purchase Option Agreements With Alcon 198
16.3.2 Jul 22, 2009: Alcon Signs Agreement With AstraZeneca On Eye Drug Development 198
16.3.3 Jun 22, 2009: Alcon Collaborates With AstraZeneca For Eye Drug Development 199
16.3.4 Oct 14, 2008: Alcon Signs Agreements With GSK and Origenis 199
16.3.5 Sep 19, 2008: Alcon To Expand Manufacturing Facility In West Virginia 200
16.4 Corporate Communications 200
16.4.1 Oct 24, 2010: Alcon Elects Daniel Vasella As New Chairman 200
16.4.2 Oct 04, 2010: Alcon Names Robert Karsunky As Senior Vice President, CFO 201
16.4.3 Oct 04, 2010: Alcon Appoints Robert Karsunky As CFO 201
16.4.4 Aug 16, 2010: Alcon Conditionally Elects Novartis-Designated Directors 202
16.4.5 May 05, 2009: Alcon Announces Board Appointments 202
16.4.6 Jan 08, 2009: Alcon Announces Executive Changes 203
16.4.7 Jan 08, 2009: Alcon Appoints Kevin Buehler As President, CEO 204
16.4.8 May 06, 2008: Alcon Announces Board Changes 204
16.4.9 Mar 10, 2008: Alcon Announces Management Changes 205
16.4.10 Sep 10, 2007: Alcon Senior Vice President To Retire 205
16.4.11 Jul 16, 2007: Alcon Appoints New CFO 205
16.4.12 Jun 26, 2007: Alcon CFO To Leave 205
16.4.13 May 09, 2007: Alcon Elects Board Members 206
16.4.14 May 02, 2006: Alcon Elects Board Members 206
16.5 Legal and Regulatory 206
16.5.1 Apr 30, 2010: Simmons Announces Settlement Of Contingent Fee Antitrust Lawsuit 206
16.5.2 Jun 26, 2007: Bausch & Lomb Files Suit Against Alcon 207
16.5.3 Jul 10, 2006: AMO Announces Patent Infringement Settlement With Alcon 207
16.5.4 Apr 05, 2006: Alcon Files Patent Infringement Suit Against Teva Pharmaceuticals 207
16.5.5 Dec 16, 2005: Alcon Will Appeal Ruling In Patent Case 208
16.5.6 May 06, 2005: Alcon Will Challenge Verdict In Patent Case 208
16.5.7 Dec 16, 2003: Alcon Views Amo Patent Lawsuit As Meritless 209
16.5.8 Dec 20, 2002: Alcon To Appeal Judges Vacating Jury Verdict Against Nidek 209
16.5.9 Oct 09, 2002: Alcon, Pharmacia Settle Intellectual Property Lawsuit 209
16.5.10 Sep 25, 2002: Alcon Victorious In Patent Lawsuit 210
16.6 Government and Public Interest 210
16.6.1 Jun 10, 2008: FDA Panel Recommends Stricter Contact Lens Labeling 210
16.7 Product News 211
16.7.1 Oct 04, 2012: Alcon’s LenSx Laser Receives FDA Clearance For Corneal Flap Creation In Corneal Refractive Procedures 211
16.7.2 Jul 19, 2012: TLC To Perform First Cataract Surgery Using Alcon’s LenSx Laser In Canada 212
16.7.3 Aug 16, 2011: NVISION Laser Eye Centers Announces Laser Refractive Cataract Surgery With Alcon’s LenSx Laser 212
16.7.4 Apr 25, 2011: Rockland Eye Physicians Use Alcon’s AcrySof IQ ReSTOR IOL To Correct Cataracts Without Glasses 213
16.7.5 Dec 06, 2010: Alcon Gains FDA Approval To Complete Voluntary Medical Device Corrective Action Plan For Its CONSTELLATION Vision System 213
16.7.6 Sep 03, 2010: Alcon Launches AcrySof IQ ReSTOR Toric Intraocular Lens Outside US 214
16.7.7 Jul 22, 2010: Alcon Announces Class I Recall Of CONSTELLATION Vision System 214
16.7.8 Dec 23, 2008: Alcon Announces FDA Approval For Its AcrySof IQ ReSTOR +3.0 D Intraocular Lens 214
16.7.9 Sep 15, 2008: Alcon Launches New AcrySof ReSTOR Intraocular Lens For Presbyopia Outside The US 215
16.7.10 Sep 12, 2008: Alcon Expands Refractive Surgery Options With The Introduction Of The AcrySof Phakic Intraocular Lens Outside The US 215
16.7.11 Jun 25, 2008: Alcon Enters Into Patent Cross-Licensing Agreement With AMO 215
16.7.12 Feb 01, 2007: Alcon’s AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens approved by FDA 216
16.7.13 Dec 18, 2006: Alcon Recalls ‘Systane Free’ Eye Drops 216
16.7.14 Dec 15, 2006: (ACL) Announces Voluntary Recall Of Systane(R) Free LIQUID GEL Lubricant Eye Drops In The United States, Including Puerto Rico. 216
16.7.15 Oct 25, 2006: Children’s Hospital of Austin is Helping Save Young Patients’ Eyesight with New Technology. 216
16.7.16 Jun 02, 2006: Alcon gets U.S. FDA approval for Ladar6000 Excimer Laser, Wavefront-Guided Hyperopia. 217
16.7.17 May 21, 2006: AcrySof IQ IOL Designated as a New Technology Intraocular Lens 217
16.7.18 Oct 12, 2005: FDA Approves Alcon’s OPTI-FREE RepleniSH MPDS 217
16.7.19 Jan 15, 2005: Combination system provides extra protection. 217
16.7.20 Mar 01, 2004: Surgeons laud various advantages of viscoelastic duo. 217
16.7.21 Feb 28, 2003: What’s Coming in 2003 217
16.7.22 Oct 24, 2002: Alcon Reports Third Quarter Operating Results 218
16.8 Product Approvals 218
16.8.1 Dec 23, 2008: Alcon Announces FDA Approval For Its AcrySof IQ ReSTOR +3.0 D Intraocular Lens 218
16.8.2 Feb 01, 2007: Alcon’s AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens approved by FDA 218
16.8.3 Feb 01, 2007: Alcon’s AcrySof ReSTOR Apodized Diffractive Aspheric Intraocular Lens Approved By FDA 218
16.8.4 Oct 12, 2005: FDA Approves Alcon’s OPTI-FREE RepleniSH MPDS 219
16.9 Other Significant Developments 219
16.9.1 May 25, 2009: Alcon begins construction of its first pharmaceutical manufacturing plant in Asia 219
16.9.2 Sep 11, 2008: Alcon Plans To Invest EUR21 million At Its Cork City Plant 219
16.9.3 Jun 20, 2008: Alcon Laboratories Spends $0.24 Million On Lobbying In Q1 2008 219
17 Appendix 220
17.1 Research Methodology 221
17.2 Secondary Research 221
17.3 Primary Research 221
17.4 Models 222
17.5 Forecasts 222
17.6 Expert Panels 222
17.7 GlobalData Consulting 222
17.8 Currency Conversion 223
17.9 Contact Us 224
17.10 Disclaimer 224


【レポート販売概要】

■ タイトル:Alcon, Inc.:市場シェア分析
■ 英文:Alcon, Inc. Market Share Analysis
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160469
■ 調査対象地域:グローバル
  • 血管ステントの世界市場予測(~2021年):ベアメタルステント、生体吸収性ステント、薬剤溶出ステント
    The vascular stent market is projected to reach USD 17.68 billion by 2021 from USD 12.21 billion in 2016, at a CAGR of 7.7% from 2016 to 2021. The growth of this market is majorly driven by factors such as technological advancements in vascular stents, increasing number of angioplasty procedures, rising burden of vascular diseases, increasing demand for minimally invasive procedures, and rising ge …
  • ディジタルホログラフィ技術の世界市場の世界市場動向及び予測
    Digital holography is a 3D technology which produces realistic 3D images of 2D objects with the help of CCD camera. Digital holography is gaining value owing to its growing applications in the medical and retail sectors. The major verticals of this technology such as medical, education, retail, and financial & banking have a large market size in terms of value. The demand for holographic display f …
  • OraSure Technologies, Inc.:市場シェア分析
    OraSure Technologies, Inc. Market Share Analysis Summary GlobalData’s new report, “OraSure Technologies, Inc. Market Share Analysis” provides in-depth information on OraSure Technologies, Inc.’s market position in the different medical equipment markets it operates in. The report provides OraSure Technologies, Inc. market share information in one key market category – Infectious Immunology. The re …
  • 拡張現実の世界市場:センサー、半導体部品、ディスプレイ、ソフトウェア
    The augmented reality (AR) market is expected to grow with a CAGR of 79.6% between 2015 and 2020. Asia-Pacific would be the fastest-growing region in the AR market. The increasing demand for AR applications and devices for 3D visualization and disease detection in the medical field would be one of the major drivers in the AR market. The increased use of AR in retail, e-commerce, architecture, and …
  • 産業用セーフティ内蔵部品の世界市場:セーフティリレー、トランスミッタ、セーフティPLC、セーフティスイッチ
    About Industrial Safety Integrated Components The processes as well as the machines in industries are becoming increasingly dynamic due to customized demand from the customers. Therefore, the need to increase productivity, safety, and flexibility in the production plants of the power, food and beverage, chemical and petrochemical, and oil and gas industries becomes necessary. The demand for integr …
  • Guardian Exploration Inc.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Guardian Exploration Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Guardian Exploration Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essentia …
  • シンガポールの生鮮キノコ市場
    About Mushrooms Mushrooms are porous, fleshy, and spongy and are most often considered as vegetables. They have both individual consumers and foodservice providers as primary consumers. Because of their medicinal and nutritional values, consumers in Singapore are willing to pay more for healthy, fresh, and hygienically-packed fresh mushrooms. However, Singapore is a net importer of fresh mushrooms …
  • 世界の保険比較・一括見積もり(ネットサイト)市場
    The emergence of online aggregators has revolutionized the distribution of insurance products and services. Distribution in the insurance industry has become increasingly diverse, with online aggregators, direct online sales, agencies, brokers, auction sites and mobile-based distribution. Online aggregators have enabled consumers to access multiple quotes from different insurance service providers …
  • アーモンドオイルの世界市場2017-2021
    About Almond OilAlmond oil is an essential oil extracted from almonds and is used for cosmetic preparations, flavoring, and medicinal purposes. There are two types of almond oil: sweet almond oil and bitter almond oil. Sweet almond oil: It is a colorless or pale yellow fatty oil extracted from the seeds of sweet almond. They are used in preparing perfumes and confections. Bitter almond oil: It is …
  • Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Summary GlobalData’s new report, “Operating Room Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Operating Room Equipment market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data …
  • IoT(モノのインターネット)テストの世界市場予測(~2021年):機能テスト、性能テスト、ネットワークテスト、セキュリティテスト、互換性テスト、ユーザビリティテスト
    “The Internet of Things (IoT) testing market is expected to grow at a CAGR of 35.4% from 2016 to 2021 owing to the rising importance of DevOps and critical need for IP and shift left testing”The IoT testing market size is expected to grow from USD 302.9 million in 2016 to USD 1,378.5 million by 2021, at a CAGR of 35.4% from 2016 to 2021. Enterprises need flexible infrastructure and platform for de …
  • 再生医療の世界市場:細胞治療、組織スキャフォールド、遺伝子治療
    About the Regenerative Medicine Market Regenerative medicine is a process of regenerating cells, tissues, and organs to restore normal function in a diseased organ. This branch of tissue engineering and molecular biology is promising and is driven by demand from patients, development of cell therapy, tissue scaffold, and gene therapy products, and increase in the number of pipeline products. Techn …
  • パーキンソン病:製薬企業動向
    PharmaPoint: Parkinson’s Disease - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Parkinson’s Disease - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Parkinson’s Disease Market. The report identifies and analyses the key companies shaping and driving the …
  • 組織アブレーションの世界市場2017-2021
    About Tissue Ablation Tissue ablation is a minimally invasive (MI), image-guided treatment modality used to treat, modify, or destroy cells (that are cancerous). In this process, a specifically equipped needle (probe) is inserted near the site of the tissue under study, and is guided by computed tomography (CT). Once the probe is in place, electricity (RFA), radio waves (microwave ablation), or li …
  • 自動車リトラクタブル・ルーフトップの世界市場2017-2021
    About Automotive Retractable Roof TopAn automotive retractable roof top (ARRT) is defined as convertible roof system, wherein the vehicle's roof can either be folded in step or part, resulting in vehicles with open roof top. The retractable hard top of the vehicle can either be operated manually or electronically, which makes the car known as a convertible in the automotive industry. Technavio’s a …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。